EDIT-301
EM-301-BThal-001
Phase 2 gene_therapy active
Quick answer
EDIT-301 for Transfusion Dependent Beta Thalassemia is a Phase 2 program (gene_therapy) at Editas Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Editas Medicine
- Indication
- Transfusion Dependent Beta Thalassemia
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active